Additionally, the reported role in breast cancer of fetal mammary developmental genes, such as TBX3, WNT-10b, FGF10, and LEF1, highlights their potential clinical relevance as biomarkers and therapeutic targets. This evidence concerns the gene TBX3 and breast cancer.